Sherpa Healthcare Partners has appointed Raymond W. Cohen as a venture partner. Cohen previously served as CEO of Axonics Inc and Vessix Vascular Inc, both of which were acquired by Boston Scientific Corporation. Sherpa focuses on investing in early- to growth-stage healthcare companies primarily in Asia, targeting pharmaceuticals, biotechnologies, medical technologies, and services. Managing partner Darren Cai expressed enthusiasm for Cohen’s extensive experience in medtech. Sherpa Healthcare Fund II raised an undisclosed amount in July 2021, with commitments from investors including the Oregon State Treasury. As of June 30, 2024, the fund had called down 74% of its capital.